Literature DB >> 17543725

Androgenetic alopecia.

Nina Otberg1, Andreas M Finner, Jerry Shapiro.   

Abstract

Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (eg, finasteride, minoxidil, or a combination of both), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Combination with hair restoration surgery leads to best results in suitable candidates. Physicians who specialize in male health issues should be familiar with this common condition and all the available approved treatment options.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543725     DOI: 10.1016/j.ecl.2007.03.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  34 in total

1.  HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial.

Authors:  Matt Leavitt; Glenn Charles; Eugene Heyman; David Michaels
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 2.  Alopecia: possible causes and treatments, particularly in captive nonhuman primates.

Authors:  Melinda A Novak; Jerrold S Meyer
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

Review 3.  The role of androgen and androgen receptor in skin-related disorders.

Authors:  Jiann-Jyh Lai; Philip Chang; Kuo-Pao Lai; Lumin Chen; Chawnshang Chang
Journal:  Arch Dermatol Res       Date:  2012-07-25       Impact factor: 3.017

Review 4.  Androgenetic alopecia: a review.

Authors:  Francesca Lolli; Francesco Pallotti; Alfredo Rossi; Maria C Fortuna; Gemma Caro; Andrea Lenzi; Andrea Sansone; Francesco Lombardo
Journal:  Endocrine       Date:  2017-03-28       Impact factor: 3.633

Review 5.  Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair Loss: A Review of the Literature.

Authors:  Andjela Egger; Sydney R Resnik; Divya Aickara; Eric Maranda; Michael Kaiser; Tongyu C Wikramanayake; Joaquin J Jimenez
Journal:  Skin Appendage Disord       Date:  2020-07-07

6.  Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans.

Authors:  Jean-Alfred Thomas; Jodi A Antonelli; Lionel L Banez; Catherine Hoyo; Delores Grant; Wendy Demark-Wahnefried; Elizabeth A Platz; Leah Gerber; Kathryn Shuler; Enwono Eyoh; Elizabeth Calloway; Stephen J Freedland
Journal:  Cancer Causes Control       Date:  2013-03-26       Impact factor: 2.506

7.  Male androgenetic alopecia: population-based study in 1,005 subjects.

Authors:  Ds Krupa Shankar; M Chakravarthi; Rachana Shilpakar
Journal:  Int J Trichology       Date:  2009-07

8.  Pharmacokinetics and pharmacodynamics of oral testosterone enanthate plus dutasteride for 4 weeks in normal men: implications for male hormonal contraception.

Authors:  John K Amory; Thomas F Kalhorn; Stephanie T Page
Journal:  J Androl       Date:  2007-11-28

Review 9.  Low-level laser (light) therapy (LLLT) for treatment of hair loss.

Authors:  Pinar Avci; Gaurav K Gupta; Jason Clark; Norbert Wikonkal; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2013-08-23       Impact factor: 4.025

10.  Scaffold-Assisted Artificial Hair Implantation in a Rat Model.

Authors:  Joshua K Au; Miguel Fernando Palma Diaz; Tara Aghaloo; Maie A St John
Journal:  JAMA Facial Plast Surg       Date:  2018-05-01       Impact factor: 4.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.